APO Research
Talk to an analyst

APO RESEARCH · REPORT

Next-Generation Sequencing (NGS) Services

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

Selected research

Market Analysis & Forecast

Global Next-Generation Sequencing (NGS) Services Market Analysis and Forecast 2026-2032

28 December 2025194 pages

Choose your research edition.

Industry ResearchNext-Generation Sequencing (NGS) Services Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Next-Generation Sequencing (NGS) Services Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Next-Generation Sequencing (NGS) Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Next-Generation Sequencing (NGS) Services Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Next-Generation Sequencing (NGS) Services Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples.

The classification of Next-Generation Sequencing (NGS) Services includes Targeted Sequencing, Whole Exome Sequencing and Whole Genome Sequencing, and the proportion of Targeted Sequencing in 2019 is about 55%.

Next-Generation Sequencing (NGS) Services is widely used in Hospitals and Clinics, Biopharma Companies, Academic & Research Organizations and Other. The most proportion of Next-Generation Sequencing (NGS) Services is Hospitals and Clinics, and the proportion in 2019 is about 56%.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 37% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of about 32%.

Eurofins Scientific, Natera, BGI, Illumina, etc. are the leaders of the industry.

Report Includes

This report presents an overview of global market for Next-Generation Sequencing (NGS) Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Next-Generation Sequencing (NGS) Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Next-Generation Sequencing (NGS) Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Next-Generation Sequencing (NGS) Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Next-Generation Sequencing (NGS) Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Next-Generation Sequencing (NGS) Services revenue, projected growth trends, production technology, application and end-user industry.

Next-Generation Sequencing (NGS) Services Segment by Company

Eurofins Scientific

Natera

BGI

Illumina

Roche

LabCorp

Berry Genomics

Brooks Life Sciences

Macrogen

Personalis

Novogene

Genotypic Technology

Dna Link

Next-Generation Sequencing (NGS) Services Segment by Type

Targeted Sequencing

Whole Exome Sequencing

Whole Genome Sequencing

Next-Generation Sequencing (NGS) Services Segment by Application

Hospitals and Clinics

Biopharma Companies

Academic & Research Organizations

Others

Next-Generation Sequencing (NGS) Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Next-Generation Sequencing (NGS) Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Next-Generation Sequencing (NGS) Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Next-Generation Sequencing (NGS) Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Next-Generation Sequencing (NGS) Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Next-Generation Sequencing (NGS) Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Next-Generation Sequencing (NGS) Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Targeted Sequencing Major Player Table 3. Whole Exome Sequencing Major Player Table 4. Whole Genome Sequencing Major Player Table 5. Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals and Clinics Major Player Table 7. Biopharma Companies Major Player Table 8. Academic & Research Organizations Major Player Table 9. Others Major Player Table 10. Next-Generation Sequencing (NGS) Services Industry Trends Table 11. Next-Generation Sequencing (NGS) Services Industry Drivers Table 12. Next-Generation Sequencing (NGS) Services Industry Opportunities and Challenges Table 13. Next-Generation Sequencing (NGS) Services Industry Restraints Table 14. Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Next-Generation Sequencing (NGS) Services Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Next-Generation Sequencing (NGS) Services Market Share by Region (2021-2026) Table 17. Global Next-Generation Sequencing (NGS) Services Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Next-Generation Sequencing (NGS) Services Market Share by Region (2027-2032) Table 19. Global Next-Generation Sequencing (NGS) Services Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Players (2021-2026) Table 21. Global Next-Generation Sequencing (NGS) Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Next-Generation Sequencing (NGS) Services Key Players Headquarters & Area Served Table 23. Global Next-Generation Sequencing (NGS) Services Players, Product Type & Application Table 24. Global Next-Generation Sequencing (NGS) Services Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Next-Generation Sequencing (NGS) Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Next-Generation Sequencing (NGS) Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Type (2021-2026) Table 31. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Type (2027-2032) Table 32. Global Next-Generation Sequencing (NGS) Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Application (2021-2026) Table 36. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Application (2027-2032) Table 37. Eurofins Scientific Company Information Table 38. Eurofins Scientific Business Overview Table 39. Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Eurofins Scientific Next-Generation Sequencing (NGS) Services Product Portfolio Table 41. Eurofins Scientific Recent Development Table 42. Natera Company Information Table 43. Natera Business Overview Table 44. Natera Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Natera Next-Generation Sequencing (NGS) Services Product Portfolio Table 46. Natera Recent Development Table 47. BGI Company Information Table 48. BGI Business Overview Table 49. BGI Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. BGI Next-Generation Sequencing (NGS) Services Product Portfolio Table 51. BGI Recent Development Table 52. Illumina Company Information Table 53. Illumina Business Overview Table 54. Illumina Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Illumina Next-Generation Sequencing (NGS) Services Product Portfolio Table 56. Illumina Recent Development Table 57. Roche Company Information Table 58. Roche Business Overview Table 59. Roche Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Roche Next-Generation Sequencing (NGS) Services Product Portfolio Table 61. Roche Recent Development Table 62. LabCorp Company Information Table 63. LabCorp Business Overview Table 64. LabCorp Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. LabCorp Next-Generation Sequencing (NGS) Services Product Portfolio Table 66. LabCorp Recent Development Table 67. Berry Genomics Company Information Table 68. Berry Genomics Business Overview Table 69. Berry Genomics Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Berry Genomics Next-Generation Sequencing (NGS) Services Product Portfolio Table 71. Berry Genomics Recent Development Table 72. Brooks Life Sciences Company Information Table 73. Brooks Life Sciences Business Overview Table 74. Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product Portfolio Table 76. Brooks Life Sciences Recent Development Table 77. Macrogen Company Information Table 78. Macrogen Business Overview Table 79. Macrogen Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Macrogen Next-Generation Sequencing (NGS) Services Product Portfolio Table 81. Macrogen Recent Development Table 82. Personalis Company Information Table 83. Personalis Business Overview Table 84. Personalis Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Personalis Next-Generation Sequencing (NGS) Services Product Portfolio Table 86. Personalis Recent Development Table 87. Novogene Company Information Table 88. Novogene Business Overview Table 89. Novogene Next-Generation Sequencing (NGS) Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Novogene Next-Generation Sequencing (NGS) Services Product Portfolio Table 91. Novogene Recent Development Table 92. Genotypic Technology Company Information Table 93. Genotypic Technology Business Overview Table 94. Genotypic Technology Next-Generation Sequencing (NGS) Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Genotypic Technology Next-Generation Sequencing (NGS) Services Product Portfolio Table 96. Genotypic Technology Recent Development Table 97. Dna Link Company Information Table 98. Dna Link Business Overview Table 99. Dna Link Next-Generation Sequencing (NGS) Services Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Dna Link Next-Generation Sequencing (NGS) Services Product Portfolio Table 101. Dna Link Recent Development Table 102. North America Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Next-Generation Sequencing (NGS) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Next-Generation Sequencing (NGS) Services Revenue by Country (2021-2026) & (US$ Million) Table 108. North America Next-Generation Sequencing (NGS) Services Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Next-Generation Sequencing (NGS) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Next-Generation Sequencing (NGS) Services Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe Next-Generation Sequencing (NGS) Services Revenue by Country (US$ Million) & (2027-2032) Table 116. China Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026) & (US$ Million) Table 117. China Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032) & (US$ Million) Table 118. China Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026) & (US$ Million) Table 119. China Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Next-Generation Sequencing (NGS) Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia Next-Generation Sequencing (NGS) Services Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia Next-Generation Sequencing (NGS) Services Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA Next-Generation Sequencing (NGS) Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA Next-Generation Sequencing (NGS) Services Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA Next-Generation Sequencing (NGS) Services Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Next-Generation Sequencing (NGS) Services Image Figure 2. Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Next-Generation Sequencing (NGS) Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Targeted Sequencing Image Figure 5. Whole Exome Sequencing Image Figure 6. Whole Genome Sequencing Image Figure 7. Global Next-Generation Sequencing (NGS) Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Next-Generation Sequencing (NGS) Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals and Clinics Image Figure 10. Biopharma Companies Image Figure 11. Academic & Research Organizations Image Figure 12. Others Image Figure 13. Global Next-Generation Sequencing (NGS) Services Market Size (US$ Million) & (2021-2032) Figure 14. Global Next-Generation Sequencing (NGS) Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Next-Generation Sequencing (NGS) Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Next-Generation Sequencing (NGS) Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Next-Generation Sequencing (NGS) Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Next-Generation Sequencing (NGS) Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Type (2021-2032) Figure 21. Global Next-Generation Sequencing (NGS) Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Application (2021-2032) Figure 24. North America Next-Generation Sequencing (NGS) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032) Figure 26. North America Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032) Figure 27. North America Next-Generation Sequencing (NGS) Services Revenue Share by Country (2021-2032) Figure 28. United States Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Next-Generation Sequencing (NGS) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032) Figure 33. Europe Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032) Figure 34. Europe Next-Generation Sequencing (NGS) Services Revenue Share by Country (2021-2032) Figure 35. Germany Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Next-Generation Sequencing (NGS) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032) Figure 45. China Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032) Figure 46. Asia Next-Generation Sequencing (NGS) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032) Figure 48. Asia Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032) Figure 49. Asia Next-Generation Sequencing (NGS) Services Revenue Share by Region (2021-2032) Figure 50. Japan Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Next-Generation Sequencing (NGS) Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032) Figure 58. SAMEA Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032) Figure 59. SAMEA Next-Generation Sequencing (NGS) Services Revenue Share by Country (2021-2032) Figure 60. Brazil Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Next-Generation Sequencing (NGS) Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Applications
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
Companies covered
  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Brooks Life Sciences
  • Macrogen
  • Personalis
  • Novogene
  • Genotypic Technology
  • Dna Link

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Next-Generation Sequencing (NGS) Services Market by Type
  3. 1.2.1 Global Next-Generation Sequencing (NGS) Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Targeted Sequencing
  5. 1.2.3 Whole Exome Sequencing
  6. 1.2.4 Whole Genome Sequencing
  7. 1.3 Next-Generation Sequencing (NGS) Services Market by Application
  8. 1.3.1 Global Next-Generation Sequencing (NGS) Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals and Clinics
  10. 1.3.3 Biopharma Companies
  11. 1.3.4 Academic & Research Organizations
  12. 1.3.5 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Next-Generation Sequencing (NGS) Services Market Dynamics
  1. 2.1 Next-Generation Sequencing (NGS) Services Industry Trends
  2. 2.2 Next-Generation Sequencing (NGS) Services Industry Drivers
  3. 2.3 Next-Generation Sequencing (NGS) Services Industry Opportunities and Challenges
  4. 2.4 Next-Generation Sequencing (NGS) Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Next-Generation Sequencing (NGS) Services Market Perspective (2021-2032)
  2. 3.2 Global Next-Generation Sequencing (NGS) Services Growth Trends by Region
  3. 3.2.1 Global Next-Generation Sequencing (NGS) Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Next-Generation Sequencing (NGS) Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Next-Generation Sequencing (NGS) Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Next-Generation Sequencing (NGS) Services Revenue by Players
  2. 4.1.1 Global Next-Generation Sequencing (NGS) Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Next-Generation Sequencing (NGS) Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Next-Generation Sequencing (NGS) Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Next-Generation Sequencing (NGS) Services Key Players Headquarters & Area Served
  7. 4.4 Global Next-Generation Sequencing (NGS) Services Players, Product Type & Application
  8. 4.5 Global Next-Generation Sequencing (NGS) Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Next-Generation Sequencing (NGS) Services Market CR5 and HHI
  11. 4.6.3 2025 Next-Generation Sequencing (NGS) Services Tier 1, Tier 2, and Tier 3
5 Next-Generation Sequencing (NGS) Services Market Size by Type
  1. 5.1 Global Next-Generation Sequencing (NGS) Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2032)
  3. 5.3 Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Type (2021-2032)
6 Next-Generation Sequencing (NGS) Services Market Size by Application
  1. 6.1 Global Next-Generation Sequencing (NGS) Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2032)
  3. 6.3 Global Next-Generation Sequencing (NGS) Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Eurofins Scientific
  2. 7.1.1 Eurofins Scientific Company Information
  3. 7.1.2 Eurofins Scientific Business Overview
  4. 7.1.3 Eurofins Scientific Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Eurofins Scientific Next-Generation Sequencing (NGS) Services Product Portfolio
  6. 7.1.5 Eurofins Scientific Recent Developments
  7. 7.2 Natera
  8. 7.2.1 Natera Company Information
  9. 7.2.2 Natera Business Overview
  10. 7.2.3 Natera Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Natera Next-Generation Sequencing (NGS) Services Product Portfolio
  12. 7.2.5 Natera Recent Developments
  13. 7.3 BGI
  14. 7.3.1 BGI Company Information
  15. 7.3.2 BGI Business Overview
  16. 7.3.3 BGI Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 BGI Next-Generation Sequencing (NGS) Services Product Portfolio
  18. 7.3.5 BGI Recent Developments
  19. 7.4 Illumina
  20. 7.4.1 Illumina Company Information
  21. 7.4.2 Illumina Business Overview
  22. 7.4.3 Illumina Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Illumina Next-Generation Sequencing (NGS) Services Product Portfolio
  24. 7.4.5 Illumina Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Roche Next-Generation Sequencing (NGS) Services Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 LabCorp
  32. 7.6.1 LabCorp Company Information
  33. 7.6.2 LabCorp Business Overview
  34. 7.6.3 LabCorp Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LabCorp Next-Generation Sequencing (NGS) Services Product Portfolio
  36. 7.6.5 LabCorp Recent Developments
  37. 7.7 Berry Genomics
  38. 7.7.1 Berry Genomics Company Information
  39. 7.7.2 Berry Genomics Business Overview
  40. 7.7.3 Berry Genomics Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Berry Genomics Next-Generation Sequencing (NGS) Services Product Portfolio
  42. 7.7.5 Berry Genomics Recent Developments
  43. 7.8 Brooks Life Sciences
  44. 7.8.1 Brooks Life Sciences Company Information
  45. 7.8.2 Brooks Life Sciences Business Overview
  46. 7.8.3 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Brooks Life Sciences Next-Generation Sequencing (NGS) Services Product Portfolio
  48. 7.8.5 Brooks Life Sciences Recent Developments
  49. 7.9 Macrogen
  50. 7.9.1 Macrogen Company Information
  51. 7.9.2 Macrogen Business Overview
  52. 7.9.3 Macrogen Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Macrogen Next-Generation Sequencing (NGS) Services Product Portfolio
  54. 7.9.5 Macrogen Recent Developments
  55. 7.10 Personalis
  56. 7.10.1 Personalis Company Information
  57. 7.10.2 Personalis Business Overview
  58. 7.10.3 Personalis Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Personalis Next-Generation Sequencing (NGS) Services Product Portfolio
  60. 7.10.5 Personalis Recent Developments
  61. 7.11 Novogene
  62. 7.11.1 Novogene Company Information
  63. 7.11.2 Novogene Business Overview
  64. 7.11.3 Novogene Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Novogene Next-Generation Sequencing (NGS) Services Product Portfolio
  66. 7.11.5 Novogene Recent Developments
  67. 7.12 Genotypic Technology
  68. 7.12.1 Genotypic Technology Company Information
  69. 7.12.2 Genotypic Technology Business Overview
  70. 7.12.3 Genotypic Technology Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Genotypic Technology Next-Generation Sequencing (NGS) Services Product Portfolio
  72. 7.12.5 Genotypic Technology Recent Developments
  73. 7.13 Dna Link
  74. 7.13.1 Dna Link Company Information
  75. 7.13.2 Dna Link Business Overview
  76. 7.13.3 Dna Link Next-Generation Sequencing (NGS) Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Dna Link Next-Generation Sequencing (NGS) Services Product Portfolio
  78. 7.13.5 Dna Link Recent Developments
8 North America
  1. 8.1 North America Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  2. 8.2 North America Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032)
  5. 8.3 North America Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032)
  9. 8.5 North America Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Next-Generation Sequencing (NGS) Services Revenue by Country
  11. 8.6.1 North America Next-Generation Sequencing (NGS) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Next-Generation Sequencing (NGS) Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Next-Generation Sequencing (NGS) Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  2. 9.2 Europe Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032)
  5. 9.3 Europe Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032)
  9. 9.5 Europe Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Next-Generation Sequencing (NGS) Services Revenue by Country
  11. 9.6.1 Europe Next-Generation Sequencing (NGS) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Next-Generation Sequencing (NGS) Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Next-Generation Sequencing (NGS) Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  2. 10.2 China Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2032)
  3. 10.2.1 China Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026)
  4. 10.2.2 China Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032)
  5. 10.3 China Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032)
  6. 10.4 China Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2032)
  7. 10.4.1 China Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026)
  8. 10.4.2 China Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032)
  9. 10.5 China Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  2. 11.2 Asia Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032)
  5. 11.3 Asia Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032)
  9. 11.5 Asia Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Next-Generation Sequencing (NGS) Services Revenue by Country
  11. 11.6.1 Asia Next-Generation Sequencing (NGS) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Next-Generation Sequencing (NGS) Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Next-Generation Sequencing (NGS) Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Next-Generation Sequencing (NGS) Services Revenue (2021-2032)
  2. 12.2 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Next-Generation Sequencing (NGS) Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Next-Generation Sequencing (NGS) Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Country
  11. 12.6.1 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Next-Generation Sequencing (NGS) Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst